CGEM
USDCullinan Therapeutics Inc. Common Stock
$7.400-0.400 (-5.128%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$7.800
High
$7.800
Low
$7.360
Volume
0.61M
Company Fundamentals
Market Cap
437.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.89M
Exchange
NMS
Currency
USD
52-Week Range
Low $5.68Current $7.400High $17.503
Related News
GlobeNewswire
Cullinan Therapeutics to Showcase New Data Demonstrating Compelling Clinical Activity for CLN-049, a Novel FLT3xCD3 T Cell Engager, in AML Patients in an Oral Presentation at the 67th ASH Annual Meeting
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ~30% CRc rate observed at clinically
View more
GlobeNewswire
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (NASDAQ:CGEM), a clinical-stage
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.